Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 13 | $54,870 |
Sells | 0 | $0 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
08 Jun 2022 15:14 | SLRX | Salarius Pharmaceuticals Inc | BURLESON TESS | Director | 07 Jun 2022 | Purchase | 27,700 | 0.18 | 4,986 | D |
08 Jun 2022 15:12 | SLRX | Salarius Pharmaceuticals Inc | LIEBER JONATHAN I | Director | 07 Jun 2022 | Purchase | 37,500 | 0.1871 | 7,016 | D |
07 Jun 2022 16:33 | SLRX | Salarius Pharmaceuticals Inc | MCVICAR WILLIAM K. | Director | 06 Jun 2022 | Purchase | 26,553 | 0.1883 | 5,000 | I |
06 Jun 2022 20:33 | SLRX | Salarius Pharmaceuticals Inc | HANISH ARNOLD C | Director | 03 Jun 2022 | Purchase | 28,000 | 0.184 | 5,152 | I |
06 Jun 2022 20:31 | SLRX | Salarius Pharmaceuticals Inc | HANISH ARNOLD C | Director | 21 Aug 2020 | Purchase A | 4,000 | 0.98 | 3,920 | I |
06 Jun 2022 20:28 | SLRX | Salarius Pharmaceuticals Inc | HANISH ARNOLD C | Director | 11 Feb 2020 | Purchase A | 4,350 | 1.15 | 5,002 | I |
06 Jun 2022 20:27 | SLRX | Salarius Pharmaceuticals Inc | HANISH ARNOLD C | Director | 25 Nov 2019 | Purchase A | 3,000 | 3.59 | 10,770 | I |
31 May 2022 17:17 | SLRX | Salarius Pharmaceuticals Inc | ARTHUR DAVID J. | Chief Executive Officer | 26 May 2022 | Purchase | 10,800 | 0.1843 | 1,990 | I |
31 May 2022 17:17 | SLRX | Salarius Pharmaceuticals Inc | ARTHUR DAVID J. | Chief Executive Officer | 26 May 2022 | Purchase | 10,392 | 0.1799 | 1,870 | I |
31 May 2022 17:17 | SLRX | Salarius Pharmaceuticals Inc | ARTHUR DAVID J. | Chief Executive Officer | 26 May 2022 | Purchase | 708 | 0.18 | 127 | I |
31 May 2022 17:17 | SLRX | Salarius Pharmaceuticals Inc | ARTHUR DAVID J. | Chief Executive Officer | 26 May 2022 | Purchase | 18,600 | 0.182 | 3,385 | D |
31 May 2022 17:17 | SLRX | Salarius Pharmaceuticals Inc | ARTHUR DAVID J. | Chief Executive Officer | 26 May 2022 | Purchase | 3,400 | 0.18 | 612 | D |
31 May 2022 17:13 | SLRX | Salarius Pharmaceuticals Inc | ROSENBLUM MARK J | Exec VP Finance, CFO | 31 May 2022 | Purchase | 28,000 | 0.18 | 5,040 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)